Luis S. Ines
Coimbra, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
SLE-DAS responder index: a novel outcome measure with high performance for physician and patient outcomes in anifrolumab phase 2-3 trials.
Journal: Rheumatology (Oxford, England)
Published: December 06, 2025
Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatment.
Journal: Annals of the rheumatic diseases
Published: July 11, 2025
EULAR recommendations for a core dataset to support clinical care and translational and observational research in systemic lupus erythematosus.
Journal: Annals of the rheumatic diseases
Published: February 13, 2025
SLE-DAS enables an accurate definition of severe lupus disease activity: derivation and validation in a post hoc study of anifrolumab phase II and III studies.
Journal: Lupus science & medicine
Published: January 03, 2025
Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set.
Journal: Seminars in arthritis and rheumatism
Published: November 07, 2024
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations.
Journal: The Lancet. Rheumatology
Published: September 27, 2024
The "target sign": A hallmark of lupus enteritis.
Journal: Reumatologia clinica
Published: July 18, 2024
OMERACT systemic lupus erythematosus domain survey.
Journal: Seminars in arthritis and rheumatism
Published: March 14, 2024
Combination treatment with rituximab and belimumab in shrinking lung syndrome in systemic lupus erythematosus.
Journal: International journal of rheumatic diseases
Published: January 25, 2024
Last Updated: 09/26/2026